Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 20 studies | 59% ± 14% | |
lung | 18 studies | 65% ± 17% | |
brain | 15 studies | 57% ± 23% | |
intestine | 13 studies | 61% ± 21% | |
eye | 11 studies | 64% ± 24% | |
kidney | 9 studies | 62% ± 18% | |
bone marrow | 7 studies | 42% ± 19% | |
lymph node | 6 studies | 66% ± 18% | |
pancreas | 5 studies | 76% ± 19% | |
uterus | 5 studies | 81% ± 13% | |
liver | 5 studies | 67% ± 14% | |
placenta | 4 studies | 66% ± 21% | |
heart | 4 studies | 33% ± 12% | |
adipose | 4 studies | 34% ± 17% | |
prostate | 4 studies | 72% ± 20% | |
breast | 4 studies | 80% ± 8% | |
adrenal gland | 3 studies | 63% ± 6% | |
esophagus | 3 studies | 63% ± 20% | |
skin | 3 studies | 77% ± 10% | |
thymus | 3 studies | 75% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 57352.23 | 2642 / 2642 | 100% | 289.63 | 705 / 705 |
esophagus | 100% | 27856.87 | 1445 / 1445 | 100% | 145.53 | 183 / 183 |
ovary | 100% | 22368.46 | 180 / 180 | 100% | 203.67 | 430 / 430 |
breast | 100% | 24074.63 | 459 / 459 | 100% | 285.55 | 1116 / 1118 |
uterus | 100% | 26992.53 | 170 / 170 | 100% | 187.59 | 458 / 459 |
bladder | 100% | 22153.52 | 21 / 21 | 100% | 180.59 | 502 / 504 |
kidney | 100% | 20467.11 | 89 / 89 | 100% | 135.15 | 897 / 901 |
thymus | 100% | 20904.10 | 651 / 653 | 100% | 244.78 | 604 / 605 |
lung | 99% | 25127.93 | 575 / 578 | 100% | 224.30 | 1154 / 1155 |
prostate | 100% | 21681.33 | 244 / 245 | 100% | 189.40 | 500 / 502 |
adrenal gland | 100% | 28026.40 | 258 / 258 | 99% | 476.93 | 228 / 230 |
intestine | 100% | 32992.92 | 966 / 966 | 99% | 198.54 | 521 / 527 |
skin | 100% | 20912.05 | 1801 / 1809 | 97% | 169.06 | 459 / 472 |
stomach | 92% | 16577.29 | 331 / 359 | 100% | 170.94 | 285 / 286 |
liver | 92% | 10821.90 | 209 / 226 | 99% | 110.92 | 401 / 406 |
pancreas | 59% | 5212.49 | 193 / 328 | 99% | 209.54 | 177 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 164.69 | 29 / 29 |
spleen | 100% | 30132.95 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 153.89 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 64.55 | 1 / 1 |
adipose | 100% | 23200.06 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 34536.08 | 1331 / 1335 | 0% | 0 | 0 / 0 |
heart | 93% | 14477.36 | 804 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 84% | 72.78 | 67 / 80 |
peripheral blood | 81% | 18015.57 | 754 / 929 | 0% | 0 | 0 / 0 |
muscle | 76% | 7349.49 | 613 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1901020 | Biological process | negative regulation of calcium ion transmembrane transporter activity |
GO_0060315 | Biological process | negative regulation of ryanodine-sensitive calcium-release channel activity |
GO_0051343 | Biological process | positive regulation of cyclic-nucleotide phosphodiesterase activity |
GO_0002027 | Biological process | regulation of heart rate |
GO_0032465 | Biological process | regulation of cytokinesis |
GO_0060316 | Biological process | positive regulation of ryanodine-sensitive calcium-release channel activity |
GO_0010881 | Biological process | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion |
GO_0010801 | Biological process | negative regulation of peptidyl-threonine phosphorylation |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0050848 | Biological process | regulation of calcium-mediated signaling |
GO_0021762 | Biological process | substantia nigra development |
GO_0031954 | Biological process | positive regulation of protein autophosphorylation |
GO_0000086 | Biological process | G2/M transition of mitotic cell cycle |
GO_0010880 | Biological process | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum |
GO_0032516 | Biological process | positive regulation of phosphoprotein phosphatase activity |
GO_0010800 | Biological process | positive regulation of peptidyl-threonine phosphorylation |
GO_1905913 | Biological process | negative regulation of calcium ion export across plasma membrane |
GO_1901844 | Biological process | regulation of cell communication by electrical coupling involved in cardiac conduction |
GO_0055117 | Biological process | regulation of cardiac muscle contraction |
GO_0071902 | Biological process | positive regulation of protein serine/threonine kinase activity |
GO_0051592 | Biological process | response to calcium ion |
GO_0035307 | Biological process | positive regulation of protein dephosphorylation |
GO_0005513 | Biological process | detection of calcium ion |
GO_0005876 | Cellular component | spindle microtubule |
GO_1902494 | Cellular component | catalytic complex |
GO_0043209 | Cellular component | myelin sheath |
GO_0031982 | Cellular component | vesicle |
GO_0005886 | Cellular component | plasma membrane |
GO_0000922 | Cellular component | spindle pole |
GO_0016020 | Cellular component | membrane |
GO_0005813 | Cellular component | centrosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0030017 | Cellular component | sarcomere |
GO_0034704 | Cellular component | calcium channel complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0097225 | Cellular component | sperm midpiece |
GO_0008076 | Cellular component | voltage-gated potassium channel complex |
GO_0005634 | Cellular component | nucleus |
GO_0031432 | Molecular function | titin binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0043539 | Molecular function | protein serine/threonine kinase activator activity |
GO_0048306 | Molecular function | calcium-dependent protein binding |
GO_0044325 | Molecular function | transmembrane transporter binding |
GO_0019855 | Molecular function | calcium channel inhibitor activity |
GO_0008179 | Molecular function | adenylate cyclase binding |
GO_0072542 | Molecular function | protein phosphatase activator activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0010856 | Molecular function | adenylate cyclase activator activity |
Gene name | CALM2 |
Protein name | Calmodulin 2 Calmodulin-2 |
Synonyms | CAM2 CAMB |
Description | FUNCTION: Calmodulin acts as part of a calcium signal transduction pathway by mediating the control of a large number of enzymes, ion channels, aquaporins and other proteins through calcium-binding . Calcium-binding is required for the activation of calmodulin . Among the enzymes to be stimulated by the calmodulin-calcium complex are a number of protein kinases, such as myosin light-chain kinases and calmodulin-dependent protein kinase type II (CaMK2), and phosphatases . Together with CCP110 and centrin, is involved in a genetic pathway that regulates the centrosome cycle and progression through cytokinesis . Mediates calcium-dependent inactivation of CACNA1C . Positively regulates calcium-activated potassium channel activity of KCNN2 . .; FUNCTION: (Microbial infection) Required for C.violaceum CopC and S.flexneri OspC3 arginine ADP-riboxanase activity. . |
Accessions | E7EMB3 ENST00000484408.5 ENST00000409563.5 ENST00000652974.1 A0A590UJC0 P0DP24 A0A590UJE2 F8WBR5 ENST00000432899.5 ENST00000272298.12 ENST00000489742.1 A0A590UJI2 |